Clinical Trial Update: Long-term Safety and Tolerability Study of Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder [Phase 3]

View source ↗

Summary

Phase 3 long-term safety and tolerability study of brexpiprazole as adjunctive treatment in major depressive disorder was terminated with posted results in 2016…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• brexpiprazole (brexpiprazole)

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Major Depressive Disorder | Phase 3 | Status: TERMINATED | Results posted: 2016-03-03